pstrongInvestors

Investors Rally as Class Action Suit Against Lantheus Holdings Unfolds: Key Dates and Allegations Revealed

by

RADNOR, Pa. – A class action lawsuit has been filed against Lantheus Holdings, Inc., aimed at investors who acquired securities of the company between February 26 and August 5, 2025. The law firm Kessler Topaz Meltzer & Check, LLP announced that those who wish to act as lead plaintiffs in the case have until November 10, 2025, to file their applications. The lawsuit alleges that Lantheus made false and misleading representations regarding the competitive standing of its product, PYLARIFY. Specifically, it claims the company failed to properly evaluate pricing and competition, leading to potential risks … Read more

Investors Alert: Biohaven Ltd. Faces Class Action Lawsuit Over Alleged Securities Violations

by

LOS ANGELES — A national law firm is reminding investors about a class action lawsuit against Biohaven Ltd. for alleged violations of federal securities laws. The Schall Law Firm is urging individuals who purchased the company’s securities between March 24, 2023, and May 14, 2025, to reach out before the upcoming deadline on September 12, 2025. The lawsuit claims that Biohaven provided misleading information regarding its drug candidate, troriluzole, which is intended for treating spinocerebellar ataxia (SCA). Additionally, the firm asserts that the company’s claims about the efficacy of BHV-7000, aimed at treating bipolar disorder, … Read more

Investors Unite: Securities Class Action Launched Against RxSight, Inc. Amid Sales Misrepresentation Claims

by

New York, Aug. 25, 2025 – A securities class action lawsuit has been initiated against RxSight, Inc., a company listed on NASDAQ under the ticker RXST, following claims that the firm misrepresented the demand for its products. This lawsuit was initiated by a shareholder on behalf of investors who purchased or acquired RxSight securities from November 7, 2024, to July 8, 2025. Investors who held shares during this specified period may be eligible to participate in the class action. Those affected are encouraged to reflect on whether they experienced any financial losses related to their … Read more

Investors Rally for Justice: Legal Action Launched Against Hims & Hers Health Amid Deceptive Practices Allegations

by

NEW YORK — Investors who experienced losses in Hims & Hers Health, Inc., are being urged to explore their legal options by a prominent law firm amid ongoing allegations against the company. Bragar Eagel & Squire, P.C., known for representing shareholders, has announced that a class action lawsuit has been initiated against Hims & Hers in the United States District Court for the Northern District of California. The lawsuit pertains to those who purchased or acquired Hims securities from April 29 to June 23, 2025, a timeframe designated as the “Class Period.” Interested investors have … Read more